Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Bagmet NN"'
Autor:
G A Shatveryan, Ratnikova Np, E. A. Lishova, G A Karagyozyan, Bagmet Nn, V. V. Nikoda, I. M. Tadzhibova, Chardarov Nk
Publikováno v:
Khirurgiya. Zhurnal im. N.I. Pirogova. :25
To analyze the immediate results of PDE in patients younger and older 70 years.The study included patients who underwent PDE for various indications from March 2010 to February 2019. All patients are divided into 2 groups:70 years old and ≥70 years
Publikováno v:
Khirurgiia. (7)
Publikováno v:
Khirurgiya. Zhurnal im. N.I. Pirogova. :4
To analyze immediate and long-term results of surgical treatment of patients with non-functioning pancreatic neuroendocrine tumors (pNETs).Outcomes in 21 patients with non-functioning pNETs were retrospectively analyzed.Long-term results were followe
Autor:
Bagmet Nn, O V Dolzhansky, Chardarov Nk, M V Hrustaleva, V V Hovrin, Ratnikova Np, G A Shatveryan, T N Galyan
Publikováno v:
Khirurgiya. Zhurnal im. N.I. Pirogova. :51
Autor:
M. I. Sekacheva, G A Shatveryan, D. N. Fedorov, Bagmet Nn, A L Bedzhanyan, Chardarov Nk, T. N. Galyan, Yu. R. Kamalov
Publikováno v:
Khirurgiya. Zhurnal im. N.I. Pirogova. :45
Liver resection remains the method of choice for treatment of colorectal liver metastases with good long-term results. Regional lymph nodes involvement is significant negative prognostic factor. Moreover, it has been considered as a contraindication
Autor:
G A Karagyozyan, Bagmet Nn, L O Polishchuk, G A Shatveryan, Chardarov Nk, Ratnikova Np, A L Bedzhanyan, K N Petrenko
Publikováno v:
Khirurgiya. Zhurnal im. N.I. Pirogova. :36
To present own experience of surgical treatment of isolated pancreatic metastases of renal cell carcinoma.There are 3 cases of pancreatic metastases of renal cell carcinoma. They were diagnosed in women aged 55, 66 and 67 years in 9, 11 and 23 years
Autor:
A L Bedzhanyan, O G Skipenko, K N Petrenko, Chardarov Nk, L O Polishchuk, G A Shatveryan, Bagmet Nn
Publikováno v:
Khirurgiya. Zhurnal im. N.I. Pirogova. :4
To study surgical and oncological outcomes in patients with metastatic colorectal liver cancer who underwent radiofrequency ablation in the structure of combined approach.It is a prospective analysis of treatment of 76 patients with metastatic colore
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Essogmo FE; Institute for Personalized Oncology, Center for Digital Biodesign and Personalized Healthcare, First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), Moscow 119991, Russia.; Cameroon Oncology Center (COC), Douala P.O. Box 1864, Cameroon., Zhilenkova AV; Institute for Personalized Oncology, Center for Digital Biodesign and Personalized Healthcare, First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), Moscow 119991, Russia., Tchawe YSN; Institute for Personalized Oncology, Center for Digital Biodesign and Personalized Healthcare, First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), Moscow 119991, Russia., Owoicho AM; Institute for Personalized Oncology, Center for Digital Biodesign and Personalized Healthcare, First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), Moscow 119991, Russia., Rusanov AS; Institute for Personalized Oncology, Center for Digital Biodesign and Personalized Healthcare, First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), Moscow 119991, Russia., Boroda A; Institute for Personalized Oncology, Center for Digital Biodesign and Personalized Healthcare, First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), Moscow 119991, Russia., Pirogova YN; Institute for Personalized Oncology, Center for Digital Biodesign and Personalized Healthcare, First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), Moscow 119991, Russia., Sangadzhieva ZD; Institute for Personalized Oncology, Center for Digital Biodesign and Personalized Healthcare, First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), Moscow 119991, Russia., Sanikovich VD; Institute for Personalized Oncology, Center for Digital Biodesign and Personalized Healthcare, First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), Moscow 119991, Russia., Bagmet NN; Petrovsky National Research Centre of Surgery, Moscow 117418, Russia., Sekacheva MI; Institute for Personalized Oncology, Center for Digital Biodesign and Personalized Healthcare, First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), Moscow 119991, Russia.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Nov 13; Vol. 15 (22). Date of Electronic Publication: 2023 Nov 13.